Phase I Trial of Granulocyte-Macrophage Colony-Stimulating Factor With High-Dose Cisplatin and Etoposide for Treatment of Small-Cell Lung Cancer: A Study of the National Cancer Institute of Canada Clinical Trials Group
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 1992
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Aged (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Carcinoma, Small Cell (MeSH)
- Cisplatin (MeSH)
- Drug Evaluation (MeSH)
- Etoposide (MeSH)
- Female (MeSH)
- Granulocyte-Macrophage Colony-Stimulating Factor (MeSH)
- Humans (MeSH)
- Lung Neoplasms (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Oncology & Carcinogenesis (Science Metrix)